Sinovac appoints chief financial officer

June 3, 2013
Manufacturing and Production, Research and Development, Sales and Marketing China, Sinovac

China-based biopharma products provider Sinovac Biotech has appointed vice president Nan Wang to be its chief financial officer. Previous CFO …

Europe image

Europe votes yes on greater trial transparency

June 3, 2013
Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency

Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …

Roche image

Lilly and Roche back US research institute

May 31, 2013
Research and Development, Sales and Marketing Roche, lilly, notre dame, research

Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …

Eylea image

NICE green light for Eylea

May 31, 2013
Sales and Marketing Bayer, NICE, Regeneron

NICE has recommended Bayer’s injection Eylea as a treatment for neovascular (wet) age-related macular degeneration (AMD) if the manufacturer offers …

Teva image

Fatality as blast rocks Teva manufacturing plant

May 31, 2013
Manufacturing and Production Teva

One man died and more than 30 other people were injured after an explosion hit a manufacturing facility operated by …

AstraZeneca image

AstraZeneca and CRUK partner on drug trial

May 31, 2013
Sales and Marketing AstraZeneca, CRUK

AstraZeneca is partnering with Cancer Research UK to develop a new oncology medicine that targets a number of different cancers. …

ramani

Avillion appoints chief business officer

May 31, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion

Venture capitalist firm Avillion has announced the expansion of its leadership team with the appointment of Ramani Varanasi as chief …

Pfizer, UCB sell plants to smaller drugmakers

May 30, 2013
Manufacturing and Production Pfizer, UCB

This week saw two pharma companies offload US manufacturing facilities to contract manufacturing organisations (CMOs), with Pfizer selling a plant …

Goldacre image

Bad pharma, good pharma: an insider’s view

May 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy

Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …

GSK image

FDA approves GSK cancer drugs

May 30, 2013
Sales and Marketing FDA, GSK

The FDA has approved two of GlaxoSmithKline’s cancer pills: BRAF-inhibitor Tafinlar and the first validated MEK-inhibitor, called Mekinist, both of …

Forxiga image

NICE U-turn on Forxiga

May 30, 2013
Sales and Marketing Forxiga, NICE

NICE has recommended Bristol-Myers Squibb and AstraZeneca’s diabetes drug Forxiga in final draft guidance after turning its back on the …

SCM Pharma appoints new director

May 30, 2013
Manufacturing and Production, Research and Development, Sales and Marketing SCM Pharma

UK-based contract development and manufacturing organisation SCM Pharma has strengthened its senior management team by recruiting a director. Paul Bradley …

Stribild image

New HIV pill for UK

May 29, 2013
Sales and Marketing Gilead, HIV, stribild

Gilead Sciences has launched Stribild, a once-daily single tablet regimen to combat HIV – the virus which causes AIDS – …

Amgen image

Amgen moves into Japanese market with Astellas deal

May 29, 2013
Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang

Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …

Novartis image

Diovan trials may have been run by Novartis staff

May 29, 2013
Research and Development, Sales and Marketing Diovan, Novartis

Several post-marketing clinical trials of the blockbuster blood pressure drug Diovan may have been run by employees of the drug’s …

Valeant to buy B+L for $8.7 billion

May 29, 2013
Sales and Marketing B+L, Valeant

Canadian firm Valeant Pharmaceuticals International is to buy Bausch + Lomb in an $8.7 billion deal which will see the …

Xarelto image

Xarelto gets ACS indication

May 29, 2013
Sales and Marketing ACS, Bayer, Xarelto

Bayer HealthCare’s bloodthinner Xarelto has expanded its reach in Europe with approval for secondary prevention after an acute coronary syndrome …

FDA image

FDA rejects Valeant’s efinaconazole on packaging grounds

May 29, 2013
Manufacturing and Production FDA, Valeant

Valeant Pharmaceuticals has had its application to market antifungal candidate efinaconazole turned down by the FDA because of issues related …

Sudair Economic City image

Pharmaniaga joins push into MENA with Saudi JV

May 29, 2013
Manufacturing and Production MENA, Pharmaniaga, Saudi

Malaysian drugmaker Pharmaniaga has formed a joint venture in Saudi Arabia as it starts a push into the fast-growing Middle …

NICE image

Grant NICE greater trial data access – report

May 29, 2013
Research and Development, Sales and Marketing Goldacre, NICE, transparency, trials

A new report by the National Audit Office says NICE should be given greater powers to access clinical trial data. …

The Gateway to Local Adoption Series

Latest content